There was several positive jobs and investments announcements by US Companies in Ireland this week. The total cumlative investment exceeds €400m and will lead to almost 500 jobs for Limerick, Cork and Dublin.
Regeneron Pharmaceuticals a leading science-driven biopharmaceutical company, announced that it is investing an additional $350 million in its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus. This will see the company add another 200 jobs, bringing the total expected job creation in the Limerick area to 500 jobs and total investment to $650 million by the end of 2017.
The company acquired the former Dell Computer facility in Limerick and achieved planning approval in April 2014 for its first IOPS site outside of the United States. When the investment was initially announced in December 2013, a $300 million investment with 300 jobs was planned for delivery by the end of 2016. With this expansion of scope, the Limerick IOPS campus will house the largest-scale bulk biologics production facility in Ireland.
With approximately 300 full-time employees, 200 contingent workers and 550 construction workers in place, recruitment is underway to bring on additional full-time, high-end specialist jobs in commercial manufacturing, process sciences, quality assurance/control and various support functions for scientists, chemists and technicians. At peak, 1,200 contractors were onsite to support development.
Leonard S. Schleifer President and Chief Executive Officer of Regeneron, said: "The Limerick facility will play an essential role in ensuring Regeneron delivers on our mission to consistently and repeatedly bring new medicines to patients with serious diseases."
Pivotal, the company accelerating digital transformation for enterprises, announced the creation of 130 new jobs and an investment of approximately €100 million in Ireland over the next five years, rapidly expanding the company's presence in the Irish market. Silicon Valley-head-quartered Pivotal is partially owned by EMC Corporation and VMware, Inc. with General Electric becoming an investor in May 2013.
Pivotal's investment marks a significant commitment to Ireland. Over the next five years, the approximate €100 million investment includes a new Pivotal Labs office in Dublin and the expansion of the company's current operations in Cork; resulting in recruitment for full-time software engineering, technical support, operational and general and administrative roles. Initially, Pivotal will be based at DogPatch Labs.
Pfizer today announced approximately 130 jobs across three manufacturing sites in Ireland including Grange Castle in Dublin and Little Island and Ringaskiddy in Cork and a recruitment drive is underway.
Pfizer employs approximately 3,200 people at six sites in Ireland across manufacturing, shared services, R&D, treasury and commercial operations and has invested $7 billion in operations in Ireland since 1969. Pfizer's operations in Ireland including recent investments of $330million are supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
Dr Paul Duffy, Vice President, Pfizer said: "Pfizer is one of Ireland's leading employers and economic contributors. Our sites in Ireland manufacture some of Pfizer's leading and newest medicines for export globally."